Daewon Pharmaceutical Co., Ltd.
Daewon Pharmaceutical Co., Ltd. is a Private limited company (Ltd.) registered in South Korea under 2078136336, and its current status with Supreme Court Internet Registry (IROS) is active. Its registered address on file is Seoul, South Korea. 5 shareholders are on record for Daewon Pharmaceutical Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Supreme Court Internet Registry (IROS) and was last updated on 25 September 2026.
Registration details
Officers
1
Directors and officers of Daewon Pharmaceutical Co., Ltd.
One officer is currently on record for Daewon Pharmaceutical Co., Ltd., filed with Supreme Court Internet Registry (IROS). Seung-ryel Baek serves as Vice Chairman, Ceo & President. Management authority at Daewon Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of Daewon Pharmaceutical Co., Ltd.
Daewon Pharmaceutical Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Daewon Healthcare co., Ltd (South Korea)
- Daewon Meditech Co., Ltd. (South Korea)
Data availability
Those 2 subsidiaries span South Korea jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Daewon Pharmaceutical Co., Ltd.
South Korea
Frequently asked questions
Who owns Daewon Pharmaceutical Co., Ltd.?
Five shareholders are currently on record for Daewon Pharmaceutical Co., Ltd., filed with Supreme Court Internet Registry (IROS). The largest of these is Fidelity Low-Priced Stock Fund, holding 90.1% — a majority holding — followed by DFA Emerging Markets Core Equity Portfolio at 4.7%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Daewon Pharmaceutical Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Daewon Pharmaceutical Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Daewon Pharmaceutical Co., Ltd. have on record?
5 shareholders are shown on record for Daewon Pharmaceutical Co., Ltd.. The register reports 10 in total; only the top 5 by holding are shown here.
What is Daewon Pharmaceutical Co., Ltd.'s company registration number?
Daewon Pharmaceutical Co., Ltd.'s registration number is 2078136336, filed with Supreme Court Internet Registry (IROS) in South Korea. Its current status on the register is active.
Is Daewon Pharmaceutical Co., Ltd. still an active company?
Daewon Pharmaceutical Co., Ltd.'s status on Supreme Court Internet Registry (IROS) is listed as active.
What is Daewon Pharmaceutical Co., Ltd.'s registered address?
The registered address on file for Daewon Pharmaceutical Co., Ltd. is Seoul, South Korea.
What legal structure is Daewon Pharmaceutical Co., Ltd. registered as?
Daewon Pharmaceutical Co., Ltd. is registered as a Private limited company (Ltd.) in South Korea.
Who are the officers/directors of Daewon Pharmaceutical Co., Ltd.?
One officer is currently on record for Daewon Pharmaceutical Co., Ltd., filed with Supreme Court Internet Registry (IROS). Seung-ryel Baek serves as Vice Chairman, Ceo & President. Management authority at Daewon Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Daewon Pharmaceutical Co., Ltd. have a parent company or subsidiaries?
Daewon Pharmaceutical Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Those 2 subsidiaries span South Korea jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Daewon Pharmaceutical Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from Supreme Court Internet Registry (IROS). Zavia's monitoring API can track changes to Daewon Pharmaceutical Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Daewon Pharmaceutical Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including South Korea, so records like Daewon Pharmaceutical Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Supreme Court Internet Registry (IROS) and was last synced on 25 September 2026.